Accomplishing 100% compliance to USP <797> is difficult. Straightforward components of <797>, such as BUD dating, which is clearly detailed in the regulations, have high levels of compliance. However, pharmacy struggles with some of the more amorphous regulations, such as providing sufficient oversight for radiopharmaceuticals. Given that the nuclear pharmacy typically has a different reporting structure and often uses a separate medication ordering system, providing oversight of their medication use can be challenging. With a new update on the horizon for <797>, and the fact that 64% of facilities have yet to achieve full compliance with the current version of the chapter, it is likely that a renewed focus on compounding practices will be necessary for most pharmacies upon release of the new chapter. The fact that some have yet to read the chapter is concerning. Hopefully, the updated version of <797> will be read thoroughly by all compounding personnel.
As we do every year, we invite you to take advantage of our Compounding Slide Kit. Pharmacy Purchasing & Products is happy to provide much of the data you find on the following pages as PowerPoint slides. You are welcome to use this data in your own presentations; we hope it serves as a valuable support as you make the case for additional investments at your facility. And you are certainly welcome to incorporate the data into presentations you may make externally to educate your colleagues on compounding opportunities they may be considering. Simply access the slides on our website (www.pppmag.com/slides).
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.